Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

217 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Open-label infliximab therapy in ulcerative colitis: a multicenter survey of results and predictors of response.
Gonzalez-Lama Y, Fernandez-Blanco I, Lopez-SanRoman A, Taxonera C, Casis B, Tabernero S, Bermejo F, Martinez-Silva F, Mendoza JL, Martinez-Montiel P, Carneros JA, Sanchez F, Maté J, Gisbert JP; Group for the Study of Inflammatory Bowel Diseases from Madrid. Gonzalez-Lama Y, et al. Among authors: mate j. Hepatogastroenterology. 2008 Sep-Oct;55(86-87):1609-14. Hepatogastroenterology. 2008. PMID: 19102352
[Role of biological markers in inflammatory bowel disease].
Gisbert JP, González-Lama Y, Maté J. Gisbert JP, et al. Among authors: mate j. Gastroenterol Hepatol. 2007 Mar;30(3):117-29. doi: 10.1157/13100073. Gastroenterol Hepatol. 2007. PMID: 17374324 Review. Spanish.
Open-label infliximab therapy in Crohn's disease: a long-term multicenter study of efficacy, safety and predictors of response.
González-Lama Y, López-San Román A, Marín-Jiménez I, Casis B, Vera I, Bermejo F, Pérez-Calle JL, Taxonera C, Martínez-Silva F, Menchén L, Martínez-Montiel P, Calvo M, Carneros JA, López P, Mendoza JL, Milicua JM, Huerta A, Sánchez F, Abreu L, López-Palacios N, Maté J, Gisbert JP; Group for the Study of Inflammatory Bowel Diseases from Madrid (ENICMAD). González-Lama Y, et al. Among authors: mate j. Gastroenterol Hepatol. 2008 Aug-Sep;31(7):421-6. doi: 10.1157/13125587. Gastroenterol Hepatol. 2008. PMID: 18783686
Methotrexate in inflammatory bowel disease: a multicenter retrospective study focused on long-term efficacy and safety. The Madrid experience.
González-Lama Y, Taxonera C, López-Sanromán A, Pérez-Calle JL, Bermejo F, Pajares R, McNicholl AG, Opio V, Mendoza JL, López P, Algaba A, Estelles J, Barbero A, Mendoza J, Maté J, Gisbert JP; Madrid Group for Study of Inflammatory Bowel Diseases (ENICMAD). González-Lama Y, et al. Among authors: mate j. Eur J Gastroenterol Hepatol. 2012 Sep;24(9):1086-91. doi: 10.1097/MEG.0b013e3283556db5. Eur J Gastroenterol Hepatol. 2012. PMID: 22713509
Systematic review: Infliximab therapy in ulcerative colitis.
Gisbert JP, González-Lama Y, Maté J. Gisbert JP, et al. Among authors: mate j. Aliment Pharmacol Ther. 2007 Jan 1;25(1):19-37. doi: 10.1111/j.1365-2036.2006.03131.x. Aliment Pharmacol Ther. 2007. PMID: 17229218 Review.
Intensification of infliximab therapy in Crohn's disease: efficacy and safety.
M Chaparro, Martínez-Montiel P, Van Domselaar M, Bermejo F, Pérez-Calle JL, Casis B, Román AL, Algaba A, Maté J, Gisbert JP. M Chaparro, et al. Among authors: mate j. J Crohns Colitis. 2012 Feb;6(1):62-7. doi: 10.1016/j.crohns.2011.07.005. Epub 2011 Aug 20. J Crohns Colitis. 2012. PMID: 22261529
217 results